Davide Corti
Overview
Explore the profile of Davide Corti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
194
Citations
19934
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bartha I, Maher C, Lavrenko V, Chen Y, Tao Q, di Iulio J, et al.
Commun Med (Lond)
. 2025 Jan;
5(1):5.
PMID: 39775203
No abstract available.
2.
Bartha I, Maher C, Lavrenko V, Chen Y, Tao Q, di Iulio J, et al.
Commun Med (Lond)
. 2024 Nov;
4(1):244.
PMID: 39578575
Background: There are three possible SARS-CoV-2 post-pandemic scenarios: (i) ongoing severity, (ii) influenza-like severity, and (iii) a transition to an endemic disease with lesser morbidity similar to that of other...
3.
Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses
Rexhepaj M, Asarnow D, Perruzza L, Park Y, Guarino B, Mccallum M, et al.
Immunity
. 2024 Nov;
57(12):2914-2927.e7.
PMID: 39488210
Porcine delta-coronavirus (PDCoV) spillovers were recently detected in febrile children, underscoring the recurrent zoonoses of divergent CoVs. To date, no vaccines or specific therapeutics are approved for use in humans...
4.
Liu P, Huang M, Guo H, McCallum M, Si J, Chen Y, et al.
Nature
. 2024 Oct;
635(8040):978-986.
PMID: 39478224
Although coronaviruses use diverse receptors, the characterization of coronaviruses with unknown receptors has been impeded by a lack of infection models. Here we introduce a strategy to engineer functional customized...
5.
Rosen L, Tortorici M, De Marco A, Pinto D, Foreman W, Taylor A, et al.
Cell
. 2024 Oct;
187(25):7196-7213.e26.
PMID: 39383863
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution has resulted in viral escape from clinically authorized monoclonal antibodies (mAbs), creating a need for mAbs that are resilient to epitope diversification....
6.
Miranda M, Kepl E, Navarro M, Chen C, Johnson M, Sprouse K, et al.
NPJ Vaccines
. 2024 Oct;
9(1):184.
PMID: 39379400
We previously described a two-component protein nanoparticle vaccine platform that displays 60 copies of the SARS-CoV-2 spike protein RBD (RBD-NP). The vaccine, when adjuvanted with AS03, was shown to elicit...
7.
Taylor R, Xiao S, Carias A, McRaven M, Thakkar D, Arainga M, et al.
AIDS Res Hum Retroviruses
. 2024 Aug;
40(11):637-648.
PMID: 39104250
Neutralizing monoclonal antibodies hold great potential for prevention of human immunodeficiency virus (HIV) acquisition. IgG is the most abundant antibody in human serum, has a long half-life, and potent effector...
8.
Paparoditis P, Fruehwirth A, Bevc K, Low J, Jerak J, Terzaghi L, et al.
Eur J Immunol
. 2024 Jul;
54(10):e2451045.
PMID: 39031535
Efficient identification of human monoclonal antibodies targeting specific antigenic sites is pivotal for advancing vaccines and immunotherapies against infectious diseases and cancer. Existing screening techniques, however, limit our ability to...
9.
Lee J, Stewart C, Schafer A, Leaf E, Park Y, Asarnow D, et al.
Nat Commun
. 2024 Jun;
15(1):5496.
PMID: 38944664
Evolution of SARS-CoV-2 alters the antigenicity of the immunodominant spike (S) receptor-binding domain and N-terminal domain, undermining the efficacy of vaccines and antibody therapies. To overcome this challenge, we set...
10.
Rexhepaj M, Park Y, Perruzza L, Asarnow D, Mccallum M, Culap K, et al.
bioRxiv
. 2024 Apr;
PMID: 38617231
Porcine deltacoronavirus (PDCoV) spillovers were recently detected in children with acute undifferentiated febrile illness, underscoring recurrent zoonoses of divergent coronaviruses. To date, no vaccines or specific therapeutics are approved for...